US Patent No. 9,309,195


Patent No. 9,309,195
Issue Date April 12, 2016
Title Salt Forms Of [r-(r*,r*)]-2-(4-fluorophenyl)-?, ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hepatanoic Acid
Inventorship Joseph Francis Krzyzaniak, Pawcatuck, CT (US)
Jason Albert Leonard, New Rochelle, NY (US)
Assignee Pfizer Inc., New York, NY (US)

Claim of US Patent No. 9,309,195

1. An atorvastatin olamine having an x-ray powder diffraction pattern containing the following 2? peaks measured using CuK?
radiation: 8.5, 9.8, 17.4, 18.6, 20.9, 22.5, and 24.1, or a solid state 19F nuclear magnetic resonance having the following
chemical shifts measured in parts per million: ?118.7.